WuXi AppTec Co Ltd H (2359)

Hong Kong
Currency in HKD
64.50
+3.15(+5.13%)
Closed
2359 Scorecard
Full Analysis
Has raised its dividend for 4 consecutive years
Earnings results expected tomorrow
Fair Value
Day's Range
61.5065.45
52 wk Range
27.5072.45
Key Statistics
Edit
Bid/Ask
64.50 / 64.55
Prev. Close
61.35
Open
61.85
Day's Range
61.5-65.45
52 wk Range
27.5-72.45
Volume
8.83M
Average Volume (3m)
5.32M
1-Year Change
57.32%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2359 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
63.89
Downside
-0.95%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Life Sciences Tools & Services industry
Show more

WuXi AppTec Co Ltd H Company Profile

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; and drug discovery services to pharmaceutical and biotech customers. In addition, the company offers consulting services for combinatorial chemistry and pharmaceuticals; and develops computer software and databases. Further, it is involved in pharmaceutical research and development; pharmacology, toxicology, and safety evaluation research services; and new drug clinical development and on-site management services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.

Employees
41116
Market
Hong Kong

Compare 2359 to Peers and Sector

Metrics to compare
2359
Peers
Sector
Relationship
P/E Ratio
22.7x27.3x−0.5x
PEG Ratio
−1.50−0.140.00
Price/Book
3.3x2.2x2.6x
Price / LTM Sales
4.8x3.9x3.0x
Upside (Analyst Target)
−0.9%16.3%56.6%
Fair Value Upside
Unlock26.8%10.1%Unlock

Analyst Ratings

13 Buy
7 Hold
1 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 63.89
(-0.95% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.77
Dividend Yield
1.69%
Industry Median 0.57%
Annualised payout
1.087
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 28, 2024
EPS / Forecast
0.8614 / 0.905
Revenue / Forecast
11.41B / 10.92B
EPS Revisions
Last 90 days

People Also Watch

26.45
6690
+6.01%
481.00
9961
+3.00%
38.05
9633
+2.70%

FAQ

What Is the WuXi AppTec H (2359) Stock Price Today?

The WuXi AppTec H stock price today is 64.50

What Stock Exchange Does WuXi AppTec H Trade On?

WuXi AppTec H is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for WuXi AppTec H?

The stock symbol for WuXi AppTec H is "2359."

Does WuXi AppTec H Pay Dividends? What’s The Current Dividend Yield?

The WuXi AppTec H dividend yield is 1.69%.

What Is the WuXi AppTec H Market Cap?

As of today, WuXi AppTec H market cap is 196.55B.

What is WuXi AppTec H Earnings Per Share?

The WuXi AppTec H EPS is 2.77.

What Is the Next WuXi AppTec H Earnings Date?

WuXi AppTec H will release its next earnings report on 16 Mar 2025.

From a Technical Analysis Perspective, Is 2359 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.